Bupivacaine Hydrochloride recalls
Bupivacaine Hydrochloride products have been recalled 12 times, most recently on 22 Apr 2026. The recalling company is usually Hospira. The most common reason is particulate matter.
Total recalls12since 2013
Last 12 months1reported
Class I542% of total
Ongoing2latest 22 Apr 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 5 42%Class II 7 58%Class III 0 0%
Why bupivacaine hydrochloride is recalled
Companies
Product types
By year
Ongoing bupivacaine hydrochloride recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bupivacaine Hydrochloride 75% in 25% Dextrose Injection recalledBupivacaine Hydrochloride | Huons Co | Sterility | Nationwide |
| Drug | CLASS I | Bupivacaine Hydrochloride Inj., USP 5 mg/mL) recalledBupivacaine Hydrochloride | Hospira Inc., A Pfizer | Particulate Matter | Nationwide |
All bupivacaine hydrochloride recalls, newest first
12 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.